BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31221274)

  • 1. Sarcopenia as an independent prognostic factor in patients with metastatic colorectal cancer: A retrospective evaluation.
    da Cunha LP; Silveira MN; Mendes MCS; Costa FO; Macedo LT; de Siqueira NS; Carvalheira JBC
    Clin Nutr ESPEN; 2019 Aug; 32():107-112. PubMed ID: 31221274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer.
    Vashi PG; Gorsuch K; Wan L; Hill D; Block C; Gupta D
    PLoS One; 2019; 14(6):e0218761. PubMed ID: 31220163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer.
    Ikeda T; Ishihara H; Iizuka J; Hashimoto Y; Yoshida K; Kakuta Y; Takagi T; Okumi M; Ishida H; Kondo T; Tanabe K
    Jpn J Clin Oncol; 2020 Aug; 50(8):933-939. PubMed ID: 32303747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.
    Demircan NC; Dane F; Ozturk MA; Babacan NA; Besiroglu M; Kaya S; Ercelep O; Tanrikulu E; Halil S; Koca S; Alan O; Hasanov R; Yumuk PF
    J BUON; 2019; 24(4):1494-1500. PubMed ID: 31646797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment.
    Ishihara H; Kondo T; Omae K; Takagi T; Iizuka J; Kobayashi H; Tanabe K
    Target Oncol; 2016 Oct; 11(5):605-617. PubMed ID: 27023922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
    Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
    Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib.
    Gökyer A; Küçükarda A; Köstek O; Hacıoğlu MB; Sunal BS; Demircan NC; Uzunoğlu S; Solak S; İşsever K; Çiçin I; Erdoğan B
    Clin Transl Oncol; 2019 Nov; 21(11):1518-1523. PubMed ID: 30868388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
    Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
    Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer.
    Wu CH; Chang MC; Lyadov VK; Liang PC; Chen CM; Shih TT; Chang YT
    Clin Nutr; 2019 Apr; 38(2):862-869. PubMed ID: 29503056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Yin C; Narumi A; Omura Y; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Kobayashi M; Araki T; McMillan DC; Miki C; Kusunoki M
    JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1322-1333. PubMed ID: 29761898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.
    Kim YY; Lee J; Jeong WK; Kim ST; Kim JH; Hong JY; Kang WK; Kim KM; Sohn I; Choi D
    Gastric Cancer; 2021 Mar; 24(2):457-466. PubMed ID: 32970267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Metastasectomy in the Multimodality Approach for
    Johnson B; Jin Z; Truty MJ; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Grothey A
    Oncologist; 2018 Jan; 23(1):128-134. PubMed ID: 28904173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.
    Feliciano EMC; Kroenke CH; Meyerhardt JA; Prado CM; Bradshaw PT; Kwan ML; Xiao J; Alexeeff S; Corley D; Weltzien E; Castillo AL; Caan BJ
    JAMA Oncol; 2017 Dec; 3(12):e172319. PubMed ID: 28796857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
    BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer.
    Xie H; Wei L; Gao S; Liu M; Liang Y; Yuan G; Wang Q; Xu Y; Tang S; Gan J
    Front Nutr; 2023; 10():1076589. PubMed ID: 36819674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib: A retrospective analysis.
    Dong D; Shi JY; Shang X; Liu B; Xu WL; Cui GZ; Wang NY
    Medicine (Baltimore); 2022 Feb; 101(5):e28680. PubMed ID: 35119010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.